BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17488788)

  • 1. Anti-Müllerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome.
    Crisosto N; Codner E; Maliqueo M; Echiburú B; Sánchez F; Cassorla F; Sir-Petermann T
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2739-43. PubMed ID: 17488788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between anti-Müllerian hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome.
    Sir-Petermann T; Ladrón de Guevara A; Codner E; Preisler J; Crisosto N; Echiburú B; Maliqueo M; Sánchez F; Perez-Bravo F; Cassorla F
    Reprod Sci; 2012 Apr; 19(4):383-90. PubMed ID: 22344736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased anti-Müllerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome.
    Sir-Petermann T; Codner E; Maliqueo M; Echiburú B; Hitschfeld C; Crisosto N; Pérez-Bravo F; Recabarren SE; Cassorla F
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3105-9. PubMed ID: 16720659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher luteinizing hormone levels associated with antimüllerian hormone in postmenarchal daughters of women with polycystic ovary syndrome.
    Crisosto N; Ladrón de Guevara A; Echiburú B; Maliqueo M; Cavada G; Codner E; Paez F; Sir-Petermann T
    Fertil Steril; 2019 Feb; 111(2):381-388. PubMed ID: 30527840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of serum adipocyte-derived proteins with insulin sensitivity and reproductive features in pre-pubertal and pubertal daughters of polycystic ovary syndrome women.
    Maliqueo M; Galgani JE; Pérez-Bravo F; Echiburú B; de Guevara AL; Crisosto N; Sir-Petermann T
    Eur J Obstet Gynecol Reprod Biol; 2012 Mar; 161(1):56-61. PubMed ID: 22277163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome.
    Sir-Petermann T; Codner E; Pérez V; Echiburú B; Maliqueo M; Ladrón de Guevara A; Preisler J; Crisosto N; Sánchez F; Cassorla F; Bhasin S
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1923-30. PubMed ID: 19223518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of hyperandrogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular mass of their daughters.
    Crisosto N; Echiburú B; Maliqueo M; Pérez V; Ladrón de Guevara A; Preisler J; Sánchez F; Sir-Petermann T
    Fertil Steril; 2012 Jan; 97(1):218-24. PubMed ID: 22088206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early metabolic derangements in daughters of women with polycystic ovary syndrome.
    Sir-Petermann T; Maliqueo M; Codner E; Echiburú B; Crisosto N; Pérez V; Pérez-Bravo F; Cassorla F
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4637-42. PubMed ID: 17848407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome.
    Maliqueo M; Sir-Petermann T; Pérez V; Echiburú B; de Guevara AL; Gálvez C; Crisosto N; Azziz R
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3282-8. PubMed ID: 19567527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Anti-Müllerian Hormone Levels in Daughters of Women with and without Polycystic Ovary Syndrome.
    Olszanecka-Glinianowicz M; Zachurzok A; Drosdzol-Cop A; Bożętowicz-Wikarek M; Owczarek A; Gawlik A; Chudek J; Skrzypulec-Plinta V; Małecka-Tendera E
    Horm Res Paediatr; 2016; 85(6):372-8. PubMed ID: 27173495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women.
    Wachs DS; Coffler MS; Malcom PJ; Chang RJ
    J Clin Endocrinol Metab; 2007 May; 92(5):1871-4. PubMed ID: 17299061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
    Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive Reproductive Phenotypes in Peripubertal Girls at Risk for Polycystic Ovary Syndrome.
    Torchen LC; Legro RS; Dunaif A
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3355-3361. PubMed ID: 30844044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.
    Pigny P; Merlen E; Robert Y; Cortet-Rudelli C; Decanter C; Jonard S; Dewailly D
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5957-62. PubMed ID: 14671196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Müllerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B.
    Chu MC; Carmina E; Wang J; Lobo RA
    Fertil Steril; 2005 Dec; 84(6):1685-8. PubMed ID: 16359965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum anti-müllerian hormone levels in women with secondary amenorrhea.
    La Marca A; Pati M; Orvieto R; Stabile G; Carducci Artenisio A; Volpe A
    Fertil Steril; 2006 May; 85(5):1547-9. PubMed ID: 16616745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome.
    Pigny P; Jonard S; Robert Y; Dewailly D
    J Clin Endocrinol Metab; 2006 Mar; 91(3):941-5. PubMed ID: 16368745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Müllerian inhibiting substance and disrupted folliculogenesis in polycystic ovary syndrome.
    Wang JG; Nakhuda GS; Guarnaccia MM; Sauer MV; Lobo RA
    Am J Obstet Gynecol; 2007 Jan; 196(1):77.e1-5. PubMed ID: 17240243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.